Global Measles Vaccine Sales Market Report 2021

1 Measles Vaccine Market Overview

• 1.1 Measles Vaccine Product Scope
• 1.2 Measles Vaccine Segment by Type
  • 1.2.1 Global Measles Vaccine Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
  • 1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
• 1.3 Measles Vaccine Segment by Application
  • 1.3.1 Global Measles Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Children
  • 1.3.3 Adults
• 1.4 Measles Vaccine Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Measles Vaccine Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Measles Vaccine Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Measles Vaccine Price Trends (2016-2027)

2 Measles Vaccine Estimates and Forecasts by Region

• 2.1 Global Measles Vaccine Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Measles Vaccine Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Measles Vaccine Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Measles Vaccine Revenue Market Share by Region (2016-2021)
• 2.3 Global Measles Vaccine Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Measles Vaccine Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Measles Vaccine Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Measles Vaccine Estimates and Projections (2016-2027)
  • 2.4.2 Europe Measles Vaccine Estimates and Projections (2016-2027)
  • 2.4.3 China Measles Vaccine Estimates and Projections (2016-2027)
  • 2.4.4 Japan Measles Vaccine Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Measles Vaccine Estimates and Projections (2016-2027)
  • 2.4.6 India Measles Vaccine Estimates and Projections (2016-2027)

3 Global Measles Vaccine Competition Landscape by Players

• 3.1 Global Top Measles Vaccine Players by Sales (2016-2021)
• 3.2 Global Top Measles Vaccine Players by Revenue (2016-2021)
• 3.3 Global Measles Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Measles Vaccine as of 2020)
• 3.4 Global Measles Vaccine Average Price by Company (2016-2021)
• 3.5 Manufacturers Measles Vaccine Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Measles Vaccine Market Size by Type

• 4.1 Global Measles Vaccine Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Measles Vaccine Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Measles Vaccine Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Measles Vaccine Price by Type (2016-2021)
• 4.2 Global Measles Vaccine Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Measles Vaccine Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Measles Vaccine Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Measles Vaccine Price Forecast by Type (2022-2027)

5 Global Measles Vaccine Market Size by Application

• 5.1 Global Measles Vaccine Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Measles Vaccine Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Measles Vaccine Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Measles Vaccine Price by Application (2016-2021)
• 5.2 Global Measles Vaccine Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Measles Vaccine Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Measles Vaccine Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Measles Vaccine Price Forecast by Application (2022-2027)

6 North America Measles Vaccine Market Facts & Figures

• 6.1 North America Measles Vaccine Sales by Company
  • 6.1.1 North America Measles Vaccine Sales by Company (2016-2021)
  • 6.1.2 North America Measles Vaccine Revenue by Company (2016-2021)
• 6.2 North America Measles Vaccine Sales Breakdown by Type
  • 6.2.1 North America Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Measles Vaccine Sales Breakdown by Type (2022-2027)
• 6.3 North America Measles Vaccine Sales Breakdown by Application
  • 6.3.1 North America Measles Vaccine Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Measles Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Measles Vaccine Market Facts & Figures

• 7.1 Europe Measles Vaccine Sales by Company
  • 7.1.1 Europe Measles Vaccine Sales by Company (2016-2021)
  • 7.1.2 Europe Measles Vaccine Revenue by Company (2016-2021)
• 7.2 Europe Measles Vaccine Sales Breakdown by Type
  • 7.2.1 Europe Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Measles Vaccine Sales Breakdown by Type (2022-2027)
• 7.3 Europe Measles Vaccine Sales Breakdown by Application
  • 7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Measles Vaccine Market Facts & Figures

• 8.1 China Measles Vaccine Sales by Company
  • 8.1.1 China Measles Vaccine Sales by Company (2016-2021)
  • 8.1.2 China Measles Vaccine Revenue by Company (2016-2021)
• 8.2 China Measles Vaccine Sales Breakdown by Type
  • 8.2.1 China Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Measles Vaccine Sales Breakdown by Type (2022-2027)
• 8.3 China Measles Vaccine Sales Breakdown by Application
  • 8.3.1 China 155 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 155 Sales Breakdown by Application (2022-2027)

9 Japan Measles Vaccine Market Facts & Figures

• 9.1 Japan Measles Vaccine Sales by Company
  • 9.1.1 Japan Measles Vaccine Sales by Company (2016-2021)
  • 9.1.2 Japan Measles Vaccine Revenue by Company (2016-2021)
• 9.2 Japan Measles Vaccine Sales Breakdown by Type
  • 9.2.1 Japan Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Measles Vaccine Sales Breakdown by Type (2022-2027)
• 9.3 Japan Measles Vaccine Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Measles Vaccine Market Facts & Figures

• 10.1 Southeast Asia Measles Vaccine Sales by Company
  • 10.1.1 Southeast Asia Measles Vaccine Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Measles Vaccine Revenue by Company (2016-2021)
• 10.2 Southeast Asia Measles Vaccine Sales Breakdown by Type
  • 10.2.1 Southeast Asia Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Measles Vaccine Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Measles Vaccine Sales Breakdown by Application
  • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Measles Vaccine Market Facts & Figures

• 11.1 India Measles Vaccine Sales by Company
  • 11.1.1 India Measles Vaccine Sales by Company (2016-2021)
  • 11.1.2 India Measles Vaccine Revenue by Company (2016-2021)
• 11.2 India Measles Vaccine Sales Breakdown by Type
  • 11.2.1 India Measles Vaccine Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Measles Vaccine Sales Breakdown by Type (2022-2027)
• 11.3 India Measles Vaccine Sales Breakdown by Application
  • 11.3.1 India Measles Vaccine Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Measles Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Measles Vaccine Business

• 12.1 GSK
  • 12.1.1 GSK Corporation Information
  • 12.1.2 GSK Business Overview
  • 12.1.3 GSK Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 GSK Measles Vaccine Products Offered
  • 12.1.5 GSK Recent Development
• 12.2 Sanofi-Pasteur
  • 12.2.1 Sanofi-Pasteur Corporation Information
  • 12.2.2 Sanofi-Pasteur Business Overview
  • 12.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Sanofi-Pasteur Measles Vaccine Products Offered
  • 12.2.5 Sanofi-Pasteur Recent Development
• 12.3 Merck
  • 12.3.1 Merck Corporation Information
  • 12.3.2 Merck Business Overview
  • 12.3.3 Merck Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Merck Measles Vaccine Products Offered
  • 12.3.5 Merck Recent Development
• 12.4 Novartis
  • 12.4.1 Novartis Corporation Information
  • 12.4.2 Novartis Business Overview
  • 12.4.3 Novartis Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Novartis Measles Vaccine Products Offered
  • 12.4.5 Novartis Recent Development
• 12.5 Pfizer
  • 12.5.1 Pfizer Corporation Information
  • 12.5.2 Pfizer Business Overview
  • 12.5.3 Pfizer Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Pfizer Measles Vaccine Products Offered
  • 12.5.5 Pfizer Recent Development
• 12.6 Serum Institute of India
  • 12.6.1 Serum Institute of India Corporation Information
  • 12.6.2 Serum Institute of India Business Overview
  • 12.6.3 Serum Institute of India Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Serum Institute of India Measles Vaccine Products Offered
  • 12.6.5 Serum Institute of India Recent Development
• 12.7 China National Biotech Group
  • 12.7.1 China National Biotech Group Corporation Information
  • 12.7.2 China National Biotech Group Business Overview
  • 12.7.3 China National Biotech Group Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 China National Biotech Group Measles Vaccine Products Offered
  • 12.7.5 China National Biotech Group Recent Development
• 12.8 Bavarian Nordic
  • 12.8.1 Bavarian Nordic Corporation Information
  • 12.8.2 Bavarian Nordic Business Overview
  • 12.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Bavarian Nordic Measles Vaccine Products Offered
  • 12.8.5 Bavarian Nordic Recent Development
• 12.9 Emergent Biosolutions
  • 12.9.1 Emergent Biosolutions Corporation Information
  • 12.9.2 Emergent Biosolutions Business Overview
  • 12.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Emergent Biosolutions Measles Vaccine Products Offered
  • 12.9.5 Emergent Biosolutions Recent Development
• 12.10 Medimmune
  • 12.10.1 Medimmune Corporation Information
  • 12.10.2 Medimmune Business Overview
  • 12.10.3 Medimmune Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Medimmune Measles Vaccine Products Offered
  • 12.10.5 Medimmune Recent Development
• 12.11 Johnson & Johnson
  • 12.11.1 Johnson & Johnson Corporation Information
  • 12.11.2 Johnson & Johnson Business Overview
  • 12.11.3 Johnson & Johnson Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Johnson & Johnson Measles Vaccine Products Offered
  • 12.11.5 Johnson & Johnson Recent Development
• 12.12 CSL Limited
  • 12.12.1 CSL Limited Corporation Information
  • 12.12.2 CSL Limited Business Overview
  • 12.12.3 CSL Limited Measles Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 CSL Limited Measles Vaccine Products Offered
  • 12.12.5 CSL Limited Recent Development

13 Measles Vaccine Manufacturing Cost Analysis

• 13.1 Measles Vaccine Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Measles Vaccine
• 13.4 Measles Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Measles Vaccine Distributors List
• 14.3 Measles Vaccine Customers

15 Market Dynamics

• 15.1 Measles Vaccine Market Trends
• 15.2 Measles Vaccine Drivers
• 15.3 Measles Vaccine Market Challenges
• 15.4 Measles Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List